These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

598 related articles for article (PubMed ID: 26332959)

  • 21. Advances in stem-cell--generated transplantation therapy for Parkinson's disease.
    Sundberg M; Isacson O
    Expert Opin Biol Ther; 2014 Apr; 14(4):437-53. PubMed ID: 24437368
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stem cell treatment for Parkinson's disease: an update for 2005.
    Snyder BJ; Olanow CW
    Curr Opin Neurol; 2005 Aug; 18(4):376-85. PubMed ID: 16003112
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stem Cell Therapy for Parkinson's Disease.
    Han F; Hu B
    Adv Exp Med Biol; 2020; 1266():21-38. PubMed ID: 33105493
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cell-based therapies for Parkinson's disease.
    Dyson SC; Barker RA
    Expert Rev Neurother; 2011 Jun; 11(6):831-44. PubMed ID: 21651331
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cell therapy for Parkinson's disease: I. Embryonic and adult donor tissue transplantation].
    Anisimov SV
    Adv Gerontol; 2008; 21(4):575-92. PubMed ID: 19432209
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel strategy for intrastriatal dopaminergic cell transplantation: sequential "nest" grafting influences survival and behavioral recovery in a rat model of Parkinson's disease.
    Timmer M; Nikkhah G
    Exp Cell Res; 2012 Dec; 318(20):2531-42. PubMed ID: 23010385
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Brain repair and reprogramming: the route to clinical translation.
    Grealish S; Drouin-Ouellet J; Parmar M
    J Intern Med; 2016 Sep; 280(3):265-75. PubMed ID: 27539906
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuronal firing activity and gene expression changes in the subthalamic nucleus after transplantation of dopamine neurons in hemiparkinsonian rats.
    Rumpel R; Alam M; Klein A; Özer M; Wesemann M; Jin X; Krauss JK; Schwabe K; Ratzka A; Grothe C
    Neurobiol Dis; 2013 Nov; 59():230-43. PubMed ID: 23938762
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human ESC-derived dopamine neurons show similar preclinical efficacy and potency to fetal neurons when grafted in a rat model of Parkinson's disease.
    Grealish S; Diguet E; Kirkeby A; Mattsson B; Heuer A; Bramoulle Y; Van Camp N; Perrier AL; Hantraye P; Björklund A; Parmar M
    Cell Stem Cell; 2014 Nov; 15(5):653-65. PubMed ID: 25517469
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regenerative medicine in Parkinson's disease: generation of mesencephalic dopaminergic cells from embryonic stem cells.
    Taylor H; Minger SL
    Curr Opin Biotechnol; 2005 Oct; 16(5):487-92. PubMed ID: 16143504
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Embryonic and adult stem cells as a source for cell therapy in Parkinson's disease.
    Levy YS; Stroomza M; Melamed E; Offen D
    J Mol Neurosci; 2004; 24(3):353-86. PubMed ID: 15655260
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Developing dopaminergic cell therapy for Parkinson's disease--give up or move forward?
    Lindvall O
    Mov Disord; 2013 Mar; 28(3):268-73. PubMed ID: 23401015
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stem cell therapies for Parkinson's disease: are trials just around the corner?
    Drouin-Ouellet J; Barker RA
    Regen Med; 2014; 9(5):553-5. PubMed ID: 25372072
    [No Abstract]   [Full Text] [Related]  

  • 34. Dopaminergic differentiation using pluripotent stem cells.
    Momčilović O; Montoya-Sack J; Zeng X
    J Cell Biochem; 2012 Dec; 113(12):3610-9. PubMed ID: 22807388
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cell replacement therapy for Parkinson's disease.
    Wijeyekoon R; Barker RA
    Biochim Biophys Acta; 2009 Jul; 1792(7):688-702. PubMed ID: 19007882
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neural transplantation: a hope for patients with Parkinson's disease.
    Lindvall O
    Neuroreport; 1997 Sep; 8(14):iii-x. PubMed ID: 9331903
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of Human Primary with Human iPS Cell-Derived Dopaminergic Neuron Grafts in the Rat Model for Parkinson's Disease.
    Peng SP; Copray S
    Stem Cell Rev Rep; 2016 Feb; 12(1):105-20. PubMed ID: 26438376
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Cell therapy for Parkinson's disease: II. Somatic stem cell-based applications].
    Anisimov SV
    Adv Gerontol; 2009; 22(1):150-66. PubMed ID: 19827685
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cell therapy for Parkinson's disease: III. Neonatal, fetal and embryonic stem cell-based applications].
    Anisimov SV
    Adv Gerontol; 2009; 22(2):296-315. PubMed ID: 19947394
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuronal transplantation and neurotrophic factors in the treatment of Parkinson's disease--update February 1995.
    Kupsch A; Oertel WH; Earl CD; Sautter J
    J Neural Transm Suppl; 1995; 46():193-207. PubMed ID: 8821056
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.